When was AccessClosure founded?

AccessClosure was founded in 2002 and raised its 1st funding round 1 year after it was founded.

Where is AccessClosure located?

AccessClosure is headquartered in Mountain View, United States.

How many employees does AccessClosure have?

As of Sep 30, 2026, the latest employee count at AccessClosure is 44.

Is AccessClosure a funded company?

AccessClosure is a funded company, having raised a total of $18.7M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2003.

When was the latest funding round of AccessClosure?

AccessClosure's latest funding was a $***** Series A round on Mar 14, 2013, with participation from 3 investors. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.59B in funding in 2026 to date.

Where does AccessClosure rank among its competitors?

AccessClosure ranks 18th amongst 393 active competitors, of which 78 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was TISSIUM, which secured $34.2M in Jun, 2026.

Who are the top competitors of AccessClosure?

AccessClosure's top competitors include TISSIUM, Advanced MedTech Solutions and Vivasure Medical. Among them, TISSIUM secured the most recent funding round in June, 2026.

AccessClosure - 2026 Company Profile, Team, Funding & Competitors

AccessClosure is an acquired company based in Mountain View (United States), founded in 2002 by Amar Sawhney. It operates as a Vascular closure device. AccessClosure has raised $18.7M in funding. The company has 393 active competitors, including 78 funded and 52 that have exited. Its top competitors include companies like TISSIUM, Advanced MedTech Solutions and Vivasure Medical.

Company Details

Access Closure, a medical device company, provides access site management products to address the challenge of vascular closure during interventional and diagnostic procedures. The company's products include Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble and extravascular sealant, which expands in the tissue tract by absorbing blood and subcutaneous fluids. On May 12, 2014, Cardinal Health completed the acquisition of AccessClosure.

Website: accessclosure.com
Social

Key Metrics

Founded Year

2002

Location

Mountain View, United States

Stage

Acquired

Total Funding

$18.7M in 6 rounds

Latest Funding Round

Series A, Mar 14, 2013, $*****

Investors

New Leaf Venture Partners & 6 more

Ranked

18^th among 393 active competitors

Employee Count

44 as on Sep 30, 2026

Similar Companies

TISSIUM & 171 more

Exit Details

Acquired by Cardinal Health (Apr 02, 2014)

View AccessClosure's full profile

AccessClosure is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Access Closure, Inc CIN: 32-0023763 , United States, Active	Dec 31, 2001	-	-	-

AccessClosure got acquired by Cardinal Health on Apr 02, 2014 at an acquisition amount of $*****.

Click here to take a look at AccessClosure's acquisition in detail

AccessClosure has raised a total funding of $18.7M over 6 rounds. Its first funding round was on 2003. Its latest funding round was a Series A round on Mar 14, 2013 for $*****. 3 investors participated in its latest round. AccessClosure has 7 institutional investors.

Here is the list of recent funding rounds of AccessClosure:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 14, 2013	7635585	Series A	3771553	1966714	9371129	9161611
Mar 22, 2012	1893125	Series A	4439845	2509337	5301084	6617585
Mar 03, 2010	3460082	Series A	2770112	5032504	7385005	1824919

Access funding benchmarks and valuations. Sign up today!

View details of AccessClosure's funding rounds and investors

The founders of AccessClosure is Amar Sawhney.

Here are the details of AccessClosure's key team members:

Amar Sawhney: Board Member and Founder of AccessClosure and founder of 3 other companies, Focaloptometria, Pramand and Incept.
Contact Info: 1 email address

View details of AccessClosure's Founder profiles and Board Members

AccessClosure's employee count trend

AccessClosure has 44 employees as of Sep 26. Here is AccessClosure's employee count trend over the years:

Uncover AccessClosure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AccessClosure include TISSIUM, Advanced MedTech Solutions and Vivasure Medical. Here is the list of Top 10 competitors of AccessClosure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TISSIUM 2013, Paris (France), Series D	Developer of vascular sealant for open vascular surgery	$190M	European Investment Fund, Cathay Capital ... & 17 others	67/100
2nd	Advanced MedTech Solutions 2012, Mumbai (India), Unfunded	Manufacturer of cardiovascular devices and surgical instruments for medical procedures	-	-	58/100
3rd	Vivasure Medical 2009, Galway (Ireland), Acquired	Developer of polymer implants and delivery systems	$92.1M	Fountain Healthcare Partners, Ascent Biomedical Ventures ... & 12 others	57/100
4th	Polymedicure 1995, Delhi (India), Public	Manufacturer of medical devices for oncology, dialysis, and respiratory care	-	ADIA, Lighthouse & 2 others	56/100
5th	Laminate Medical 2012, Rehovot (Israel), Series C	Device to prevent AV Fistula failure by promoting their maturation and patency	$20M	Valiance Asset Management, Haisco Pharmaceutical Group ... & 25 others	54/100
6th	revmedica 2017, Durham (United Kingdom), Series A	Developer of a laparoscopic surgical stapler	$14.2M	ABCT, MassChallenge & 5 others	54/100
7th	Access Vascular 2015, Bedford (United States), Series C	Developer of hydrogel-based devices to improve venous access	$54.3M	TVM Capital Life Science	52/100
8th	Ceterix 2010, Menlo Park (United States), Acquired	Suture passer for orthopedic srugery	$73.9M	Versant Ventures, CRG & 7 others	52/100
9th	Lexington Medical 2013, Watertown (United States), Late Stage	Abdominal surgical instruments.	$37.8M	LSG Holdings, Ampersand Capital & 3 others	52/100
10th	EKOS Corporation 1995, Bothell (United States), Acquired	Developer of a device for thrombolysis to treat pulmonary embolism	$58.8M	Trellis Partners, Hercules Capital & 17 others	52/100
18th	AccessClosure 2002, Mountain View (United States), Acquired	Vascular closure device	$18.7M	New Leaf Venture Partners, Industry Ventures ... & 5 others	48/100